Completed from United Kingdom
The Graduate Certificate in Health Economics (Intermediate) at Stanmore School of Business exceeded my expectations. The modules on cost‑effectiveness analysis and health technology assessment directly aligned with my goal of influencing NHS budgeting decisions. I was able to apply the newly learned incremental cost‑effectiveness ratio (ICER) calculations to a real‑world case study on a new oncology drug, which I later presented to my department. The course materials were up‑to‑date, with clear lecture notes and interactive Excel models that made complex concepts accessible. Overall, the learning experience was highly professional and I feel fully equipped to contribute to policy‑making discussions.
I took the intermediate health economics certificate because I wanted to get a better handle on value‑based pricing in the US healthcare market. The course was laid out in a relaxed, easy‑going way that made the heavy theory feel manageable. I especially liked the practical labs where we built a simple Markov model to predict outcomes for a chronic disease program. The reading list was spot‑on – recent journal articles mixed with classic textbooks. By the end of the program I could actually walk into a meeting and talk about quality‑adjusted life years (QALYs) without fumbling. Definitely a solid step forward for my career.
Wow! This course was exactly what I needed to boost my confidence in health economics. The enthusiastic teaching style kept me engaged, and the hands‑on assignments—like the budget impact analysis for a new vaccine—gave me real‑world skills I can use back home in India. The materials were vibrant, with lots of visual aids and up‑to‑date policy examples from both developed and emerging markets. I now feel capable of advising my NGO on cost‑effectiveness thresholds and have already drafted a proposal using the techniques I learned. Absolutely love the experience!
The intermediate health economics certificate offered a detailed and rigorous curriculum that matched my learning objectives. Each module delved deeply into topics such as willingness‑to‑pay thresholds, discounting, and the application of decision‑analytic modelling. I particularly appreciated the comprehensive case study on South African HIV program financing, which allowed me to practice sensitivity analysis using STATA. The course packets were well‑organized, and the supplementary webinars with industry experts added relevance. My overall experience was highly satisfactory; I now possess the analytical toolkit required for my role in a health ministry advisory board.
